Showing results (1-10 of 50) with videos related to
Sort By:
Pageof 5
Plos One|October 14, 2009
Searching for new clues about the molecular cause of endomyocardial fibrosis by way of in silico proteomics and analytical chemistryMisaki WayengeraBMC Blood Disorders|May 16, 2012
Zinc finger nucleases for targeted mutagenesis and repair of the sickle-cell disease mutation: An in-silico studyMisaki WayengeraTheoretical Biology & Medical Modelling|February 18, 2010
On the general theory of the origins of retrovirusesMisaki WayengeraTheoretical Biology & Medical Modelling|July 31, 2012
Zinc finger arrays binding human papillomavirus types 16 and 18 genomic DNA: precursors of gene-therapeutics for in-situ reversal of associated cervical neoplasiaMisaki WayengeraTheoretical Biology & Medical Modelling|June 28, 2011
Identity of zinc finger nucleases with specificity to herpes simplex virus type II genomic DNA: novel HSV-2 vaccine/therapy precursorsMisaki WayengeraTheoretical Biology & Medical Modelling|July 26, 2011
Proviral HIV-genome-wide and pol-gene specific zinc finger nucleases: usability for targeted HIV gene therapyMisaki WayengeraTheoretical Biology & Medical Modelling|March 20, 2009
Theoretical basis for reducing time-lines to the determination of positive Mycobacterium tuberculosis cultures using thymidylate kinase (TMK) assaysMisaki WayengeraTheoretical Biology & Medical Modelling|July 31, 2009
In silico evidence for the species-specific conservation of mosquito retroposons: implications as a molecular biomarkerWilson Byarugaba, Henry Kajumbula, Misaki WayengeraThe Open AIDS Journal|March 11, 2009
Harnessing pharmacogenomics to tackle resistance to the "nucleoside reverse trancripatse inhibitor" backbone of highly active antiretroviral therapy in resource limited settingsMisaki Wayengera, Henry Kajumbula, Wilson ByarugabaTheoretical Biology & Medical Modelling|August 9, 2008
Identification of restriction endonuclease with potential ability to cleave the HSV-2 genome: inherent potential for biosynthetic versus live recombinant microbicidesMisaki Wayengera, Henry Kajumbula, Wilson ByarugabaPageof 5